MedTrace Logo

Retrospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital

NCT02667028 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2016-01-28

No results posted yet for this study

Summary

Coronary heart disease (CHD) has a serious health threaten to population. PCI is a well-proved measure in CHD management. However, the knowledge about the real-life PCI use and how evidence-based therapies in routine clinical practice is limited. In a large-scale hospital in Northeast China, the investigators will examine various factors of 3007 consecutive PCI inpatient cases from January 1, 2010 to October 31, 2014. The medical records will be reviewed and abstracted to evaluate the clinical treatment pattern and outcomes. Basic data and innovative evidence will accelerate evidence-based clinical practice, and improve patients' outcomes in future finally.

Conditions

Interventions

PROCEDURE

PCI

percutaneous coronary intervention

Sponsors & Collaborators

  • Shengjing Hospital

    lead OTHER

Principal Investigators

  • tongtong yu, Doctor · Shengjing Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02667028 on ClinicalTrials.gov